RIA Advisory Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$633K Sell
2,393
-29,371
-92% -$7.75M 0.18% 69
2026
Q2
$8.07M Buy
31,764
+923
+3% +$215K 1.76% 13
2026
Q1
$7.54M Buy
30,841
+25,281
+455% +$5.89M 1.79% 10
2025
Q4
$1.15M Buy
5,560
+3,806
+217% +$753K 0.28% 57
2025
Q3
$325K Sell
1,754
-34,767
-95% -$5.96M 0.08% 104
2025
Q2
$5.58M Buy
36,521
+794
+2% +$122K 1.64% 18
2025
Q1
$5.92M Sell
35,727
-1,617
-4% -$253K 1.93% 10
2024
Q4
$5.4M Buy
37,344
+6,308
+20% +$978K 1.84% 11
2024
Q3
$5.03M Buy
+31,036
New +$4.94M 1.78% 11
2024
Q1
$4.55M Buy
+28,756
New +$4.58M 1.84% 11
2023
Q4
– Sell
-2,740
Closed -$427K – 145
2023
Q3
$427K Sell
2,740
-26,783
-91% -$4.42M 0.19% 68
2023
Q2
$4.89M Buy
29,523
+954
+3% +$154K 2.1% 7
2023
Q1
$4.43M Buy
28,569
+2,486
+10% +$401K 2.04% 7
2022
Q4
$4.47M Buy
+26,083
New +$4.5M 2.59% 9

Other funds holding JNJ

RIA Advisory Group's JNJ Position: Q3 2026 in Review

RIA Advisory Group reduced its Johnson & Johnson (JNJ) stake by 92% in Q3 2026, selling an estimated $7.75M and leaving 2,393 shares worth $633K. The position accounts for 0.18% of the portfolio, ranked #69.

RIA Advisory Group first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. The position peaked at $8.07M in Q2 2026. 3,394 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • RIA Advisory Group held 2,393 shares of Johnson & Johnson worth $633K as of Q3 2026.
  • RIA Advisory Group sold 29,371 Johnson & Johnson shares in Q3 2026, an estimated $7.75M.
  • Johnson & Johnson made up 0.18% of RIA Advisory Group's portfolio in Q3 2026, its #69 holding.
  • RIA Advisory Group first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • RIA Advisory Group's Johnson & Johnson position peaked at $8.07M in Q2 2026.
  • 3,394 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on RIA Advisory Group's 13F filing for Q3 2026, filed 15 Oct 2026.